Matrix Therapy Company in Regenerative Medecine

Home
About us
Our Science
Our Products
Events & News
Contact

Feb 10, 2022 – Clinical

OTR3 announces first patient enrolled in a post market clinical follow up on Cacipliq 20®..

Nov 9, 2021 – Clinical Mar 25, 2022 – Clinical